Impella CP® Helps to Prevent a “Heart Attack Waiting to Happen”
Watching His Own Procedure
Rogelio Back on the Go
“I like to inject physical activity whenever I can,” he said.
Since the procedure, in addition to his work in education to help the disadvantaged, Rogelio has become a “heart recovery advocate.” Working with Abiomed and other Impella patients around the country, he tells his story so that others might benefit from his experience, including testifying before an FDA panel about heart devices like Impella CP. He also was a speaker at “goREDTALKS,” a showcase of speakers not unlike Ted Talks, at the Detroit Medical Center Heart Hospital in September 2016. “More patients, physicians and payers need to know about alternatives, such as using a device like Impella CP for pre-emptive or preventive purposes rather than just a means to survival”, he said.
Impella CP is now available to more patients: In December 2016 , the FDA gave approval to the Impella CP to provide treatment for patients with high-risk percutaneous intervention procedures. This approval expands the patient population that can be safely and effectively treated with Impella CP in the high-risk PCI setting.
“My message is – why have a heart attack if you don’t have to?” Rogelio said.
Making heart repair safer for no-option patients recommended for a PCI procedure
- The world’s smallest heart pump
- Impella® is a heart pump intended for temporary (≤ 6 hours) use by patients with severe symptomatic CAD and diminished (but stable) heart function who are undergoing PCI but are not candidates for surgical coronary bypass treatment
Impella® makes Protected PCI possible
Ask Your Cardiologist About Protected PCI
While your cardiologist will discuss treatment options with you, a Heart Team will evaluate you to recommend the option that’s right for you.